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Abstract
Background: Growth factors such as nerve growth factor (NGF) and insulin-like growth factor-1 (IGF-1) have been
shown to play a role in the healing process of nerve injury. Recent researches have also shown that oxytocin
administration activates these growth factors of importance for the healing of nerve tissue. The objective of the
present study was to evaluate the effects of oxytocin on peripheral nerve regeneration in rats.
Methods: Twenty-four male Sprague-Dawley rats were underwent transection damage model on the right sciatic
nerve and defective damage model on the left sciatic nerve. The animals were assigned to one of two groups: control
group or treatment group (received 80 mg/kg oxytocin intraperitoneally for 12 weeks). The sciatic nerve was examined,
both functionally (on the basis of climbing platform test) and histologically (on the basis of axon count), 3, 6, 9, and
12 weeks after the injury. Also, stereomicroscopic and electrophysiological evaluations were carried out.
Results: Significantly greater improvements in electrophysiological recordings and improved functional outcome
measures were presented in the treatment group at 12-week follow-up. Stereomicroscopic examinations
disclosed prominent increases in vascularization on proximal cut edges in the oxytocin group in comparison with
the control group. Higher axon counts were also found in this group.
Conclusion: Intraperitoneal oxytocin administration resulted in accelerated functional, histological, and
electrophysiological recovery after different sciatic injury models in rats.
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Background
Treatment of peripheral nerve injuries is still challenging
and may lead to considerable disability. Besides the treat-
ment of transection injuries, especially those that result in
large gaps between nerve ends are particularly trouble-
some [1–3]. Pharmacologic agents and immune system
modulators have been investigated for the purpose of
enhancing nerve regeneration [4, 5–10]. However, there is
not any drug in clinical use proved to be effective in nerve
regeneration. On the other hand, clinical and experim-
ental researches have achieved a remarkable progress in
understanding the neurobiology involved in nerve injury
over the last decades. A number of molecules such as
nerve growth factor (NGF) and insulin-like growth
factor-1 (IGF-1) have been shown to enhance nerve re-
generation and promote axonal growth rate [8–10].
Oxytocin has been shown to play an important role in
wound healing via modulating stress responses. Besides,
well-controlled animal studies suggest that oxytocin has
a direct influence on the healing process due to its anti-
inflammatory properties and via modulating some import-
ant cytokines [10–13]. Recent researches have shown that
exogenous administration of oxytocin increases the plasma
levels of NGF and IGF-1. These neurotropic factors have
shown to improve nerve healing. Therefore, oxytocin may
influence the peripherical nerve healing positively by in-
creasing the plasma levels of these important cytokines
[14–17]. Our hypothesis in the present study was that oxy-
tocin would enhance healing following peripheral nerve
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injury and this may lead to have better outcomes after per-
ipheral nerve injuries especially on orthopaedic and
trauma surgery.
In this study, we evaluate the effects of oxytocin ad-
ministration on peripheral nerve regeneration using an
established rat sciatic nerve injury models in male Sprague-
Dawley rats.
Material and methods
Twenty-four male Sprague-Dawley rats weighing approxi-
mately 200 g were used in the present study. All animal
experiments were performed with the approval of the in-
stitutional animal care and use committee. All rats were
provided with autoclaved pellets and water ad libitum.
The rats were permitted 1 week to acclimate to their en-
vironment prior to the study. The animals were housed
under a 12-h light/dark cycle. All experimental procedures
were underwent under aseptic conditions and were com-
pleted in accordance with the National Institutes of Health
guidelines on the care and use of laboratory animals for
research purposes.
The animals were randomly divided into two groups,
each group consisting of 12 animals. Group I (treatment
group) received 80 mg/kg oxytocin intraperitoneally for
12 weeks (Pituisan 50 ml) [EGE-VET]. Group II (control
group) received 1 cm3 physiologic serum intraperitone-
ally for 12 weeks so as to refrain from effects of injection
stress. The animals were handled on a daily basis for 1-
week period prior to the study (Fig. 1).
Surgical procedure
All rats were anesthetized with 50 mg/kg Ketamine-HCl
(Alfamine®) and 10 mg/kg Ksilazin HCl (Alfazyne) ad-
ministered intraperitoneally. The surgical site was shaved
and was washed with antiseptic solution prior to posi-
tioning for surgery. Thereafter, local anesthetic (0.5 mL
of 1 % lidocaine hydrochloride) was injected subcutane-
ously at the surgical site. The sciatic nerve on both sides
was approached via semitendinosus-biceps femoris (long
head) muscle-splitting incision. After nerve dissection
were carried out, transection and defect model was per-
formed at the right and left limbs, respectively. Excision
of 10 mm segment from the sciatic nerve was performed
in order to obtain a defective nerve model. The wound
was closed with 4-0 sutures for the skin. Follow-ups were
done at 0, 1, 3, 9, and 12 weeks and one animal in each
group were sacrified at each time interval. The nerve regen-
eration and functional recovery were evaluated by stereomi-
croscopic observation [SOIF XLB45-B3 +MD30 3.2 MP]
and by electrophysiological and histologic analyses.
Histological evaluation: axon count of sciatic nerve tissue
Following nerve stimulation, the rats were sacrificed.
Thereafter, sections measuring 0.5 cm in length were
removed from the sciatic nerves, 0.5 cm proximal and
0.5 cm distal to the site of injury. The nerve tissue samples
were embedded in paraffin and stained with hematoxylin
and eosin blue. Histomorphometric analysis was performed
with the use of an SOİF SZM 45 T2 Trinoculer Stero-
Microscope with a MD 30 camera for axon counts per
unit area. In all animals, the corresponding sections
were harvested and processed in a similar manner; the
axon counts were performed blinded by a investigator
with a light microscope.
Electrophysiologic evaluation
Investigators who were unaware of the treatment pro-
cedure performed the electrophysiological investigations.
The results of the EMG (electromyography) tests com-
prised both amplitude and latency measures. EMG re-
cordings were carried out with the use of MP30 data
acquisition and analysis system (Biopac Systems Inc.,
CA, USA). Proximal electrode was placed slightly distal
to the sciatic notch. Distal electrode was placed initially
Fig. 1 a Stereomicroscopic photograph of nerve regeneration in
oxytocin treatment group. Axonal sprouting (arrows) is pronounced
and joins the nerve ends at the third-week follow-up. b Completion
of nerve healing and maturation of the axonal sprouting at the
12-week follow-up (circled zone). The distal stump revealed
considerable increase in diameter
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at the second web space of the foot and later on moved
distally at the gastrocnemius (GM) muscle to obtain bi-
polar recording.
Functional evaluation
The functional assessments of the sciatic nerve recovery
were performed by measuring the maximum angle at
which the animals were able to climb upon an inclined
plane (climbing degrees) which is sensitive in detecting
5-degree difference. The maximum angle at which an
animal could support its weight was measured. Climbing
level achieved in each group was recorded periodically.
Statistical analysis
All statistical analyses were conducted using the SPSS
15.0 program. The Student t and ANOVA tests were used
to determine differences in the parametric values when-
ever necessary between the groups. The Mann-Whitney U
test was used to evaluate the nonparametric values. The
level of significance was set at P < 0.05.
Results
The mean body weight of the rats before the surgery
and at follow-ups was similar in both groups revealing
no significant difference.
At one, 3 and 9 weeks follow-ups, higher number of
axons were counted in the treatment group among the
rats that were sacrified in comparison with the control
group. After 12 weeks, all the animals were sacrified and
underwent histological assessment. The samples obtained
at the right sciatic nerve in oxytocin group presented an
ongoing degenerative process. The results at 12 weeks
revealed significant difference between the treatment and
control group. A significantly higher number of axons
were counted distal to the injury in the group of rats that
received oxytocin treatment in comparison with the group
that received normal saline solution. Table 1 presents the
comparison of axon counts of two groups at follow-ups
and after completion of the study in detail.
Functional assessment of the rats revealed similar re-
sults before the operation. Average climbing degree was
70° in each group. Significantly greater climbing degrees
were measured at 1 and 12 weeks in the treatment group
in comparison of the control group. Table 2 presents the
functional assessments in detail at the follow-ups.
At postoperative, 1, 3, or 6 weeks group patterns were
basically very similar, and there was no EMG response
when the distal electrode was located at the second web
space. The EMG recordings were carried out via positing
the distal electrode at the second web space and GM
muscle, respectively, after postoperative 9 weeks. There
was no EMG response in both groups when the distal
electrode was at the second web space. However, EMG
responses were noted at the right side recordings (tran-
section) in the treatment group after replacement of the
electrode at the GM muscle at 9-week follow-up. This
difference was obtained with regard to amplitude only
whereas latency patterns were similar. After 12 weeks,
EMG recordings revealed a significant difference in the
treatment group with regard to both amplitude and la-
tency in comparison with the control group. The latency
recordings were significantly shorter in the treatment
group whereas the amplitude measures revealed signifi-
cantly higher results (Fig. 2).
On the other hand, similar improvements in EMG
recordings were seen at the left side (defect model) in the
treatment group revealing shorter latency periods and
higher amplitude levels when compared with the control
group at 12-week follow-up. The results of the electro-
diagnostical evaluation are summarized in Tables 3 and 4.
Stereomicroscopic evaluations of the right sciatic
nerve (transection) after the first week revealed that
the revascularization at the proximal site of the injury
was more prominent. Besides, the diameters of the
vessels were larger, and the walls of the vessels were
thicker when compared with the control group in the
treatment group.
Axonal sprouting was observed in both nerve damage
models in both groups after 3 weeks. This sprouting has
been observed to reach the distal site of the injury in the
transected sciatic nerves in both groups after 9 weeks.
Nerve fibers crossed the lesioned region and reached the
distal stump joining the nerve stumps in both groups.
However, the maturation of the sprouting was more pro-
nounced in the treatment group.
Table 1 Body weight measurements (grams)
Follow-up
period
Treatment group Control group P value
Mean ± SS Mean ± SS
Before surgery 195.83 ± 5.15 197.08 ± 4.64 0.187
1 week 203.33 ± 8.88 206.04 ± 10.53 0.342
3 weeks 219.09 ± 25.08 222.73 ± 21.64 0.203
6 weeks 261 ± 36.95 261.5 ± 35.28 0.969
9 weeks 277.78 ± 47.38 277.22 ± 49.09 0.824
12 weeks 284.29 ± 41.98 272 ± 54.01 0.220









1 week 480.2 ± 27.4 460 ± 13 330.5 ± 19.6 213 ± 24
3 weeks 695.8 ± 41.5 303.33 ± 20.06 327.5 ± 21.7 202.5 ± 18.33
9 weeks 620.3 ± 20 360.30 ± 28 380.4 ± 12.1 320.6 ± 11
12 weeks 443.8 ± 35.9 362.4 ± 16.7 318.6 ± 14.06 249.6 ± 21.4
P values were P < 0.01 and P < 0.005, respectively, after comparison of right
(transection) and left (defect) models among the groups after 12 weeks
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Discussion
The functional assessment in the present study revealed
that oxytocin group presented significant difference with
regard to functional outcome at 12-week follow-up. Al-
though we saw a positive effect on nerve regeneration
with oxytocin, functional measures failed to demonstrate
complete improvement in the recovery from injury. The
complete functional recovery might have been observed
with prolongation of the experiment time.
Wallerian degeneration is a process of progressive dis-
integration and demyelination of the distal axonal segment
following the damage to the neuron [1]. A pronounced
increase in wallerian degeneration was seen in both groups
at the first week whereas epinoral fibrosis was significantly
higher in control group. An increase in axon count in com-
parison with the control group was noted at 12 weeks in
treatment group. Our findings revealed that nerve transec-
tion model was superior to gap model at all follow-ups
Fig. 2 Electromyograph recordings of the right limb (transection model) obtained after 9 weeks. a Control group. b Treatment group
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with regard to histological improvement. The nerve-
transection model in oxytocin group presented signifi-
cant difference in axon count compared with the control
group. This difference was also noted in nerve defect model
at the 12-week follow-up. This study herein presented that
oxytocin enhances a better histological improvement
in two different injury models in rats. This improve-
ment was obvious at earlier follow-ups and continued
throughout the study.
We assessed that the degree of recovery of sciatic nerve
function was assessed via climbing test, which provided a
noninvasive and easily quantifiable method in the rat
model when both limbs were injured [18]. Goldshmit Y et
al. investigated the effect of exercise on axonal regrowth
and found positive results with the climbing tests. Our re-
sults present the positive effect of oxytocin administration
in terms of functional recovery [19]. Our data showed sig-
nificant difference at 12 weeks in functional evaluation
between group comparisons. Moreover, animals able to
climb onto the platform from higher grid levels in the
treatment group comparable to the preoperative levels.
We can speculate that the animals might have shown
more improvements if the study duration was prolonged
presenting full functional recovery.
Electrophysiologic measurements reflect the functional
behavior of the regenerated nerve [1, 2]. Dose F et al.
reported the low doses of oxytocin synergism with
electrical afferent stimulation after spinal cord injury
and similarly [20], our findings indicate that adminis-
tration of oxytocin significantly provides lower latency
recordings and higher amplitude measures reflecting a
higher number of normally functioning axons in the
treatment group.
Taken together, these data indicate that administration
of oxytocin promotes functional recovery and enhances
nerve regeneration after sciatic nerve damage in the rat.
In the present study, we observed that the improvement
in functional recovery was accompanied by significant
increases in axon counts in the nerve regeneration site
as well as close observations via stereomicroscopic eval-
uations. At the microscopic level, there was also con-
tinuity across the transection site and the defective site
as well in the treatment group after 12 weeks. The ob-
served improvement in the axon regeneration is in agree-
ment with the results.
There is increasing evidence that growth factors may act
at multiple levels in the regenerative response of nerve
healing [8–11]. One such factor affecting multiple cell
processes is IGF-1 and NGF. IGF-1 accelerates glucose
uptake in the cells, stimulates mitotic activity and cell pro-
liferation, and also inhibits apoptosis. NGF is a member of
a family known as neurotrophins that function as signal-
ing molecules. These cytokines are important for the
growth, maintenance, and survival of neural cells [11, 12].
It has been well documented in the related literature
that oxytocin influences plasma levels of some growth
factors that play important role in the healing process of
damaged tissues [15, 21]. Luppi et al. have reported that
an intravenous injection of oxytocin results in a three-
fold increase in NGF [15]. Another important study by
Gavrilenko et al. revealed that oxytocin resulted in sig-
nificant differences of wound process characteristics as
compared with those ones in control group in the treat-
ment of complex diabetic foot ulcers [19]. The authors
presented in their work that oxytocin activates the pro-
cesses of neovascularization, proliferation of endothelio-
cytes and histiocytes, resulting in the effective clearance
of the wound, and optimal granulation tissue formation.
Peterson et al. revealed in his study that oxytocin en-
hances the survival of musculocutaneous flaps via in-
creasing plasma IGF-1 levels. The authors revealed that
this positive effect blocked by administration of an oxy-
tocin antagonist [17]. The present study demonstrated
that oxytocin enhances peripheral nerve regeneration in
a rat sciatic damage model. This positive impact can be
attributed to the benefits of oxytocin in stimulating the
nerve growth factors that obviously presented in the
Table 3 Functional evaluation via climbing degrees
Follow-up
period
Treatment group Control group P value
Mean ± SS Mean ± SS
1 week 58.33 ± 2.46 55.63 ± 3.99 0.001 (p< 0.05)
3 weeks 55.45 ± 2.7 55.91 ± 2.51 0.562
6 weeks 55.5 ± 2.84 56.25 ± 2.75 0.353
9 weeks 57.78 ± 2.64 56.94 ± 3.49 0.258
12 weeks 57.5 ± 5.46 53.57 ± 4.76 0.002 (p < 0.05)
Table 4 Comparison of EMG recordings between groups
Treatment group Control group P values
Right Left Right Left R/L
(Transection) (Defect) (Transection) (Defect)
9 weeks (amplitude) 12.25 ± 1.57 8.47 ± 1.87 6.99 ± 0.90 6.10 ± 1.53 0.002/0.171
9 weeks (latency) 1.25 ± 0.03 1.31 ± 0.04 1.22 ± 0.02 1.27 ± 0.04 0.27/0.269
12 weeks (amplitude) 12.92 ± 2.86 11.17 ± 1.60 8.34 ± 0.42 7.75 ± 0.68 0.011/0.039
12 weeks (latency) 1.05 ± 0.01 1.12 ± 0.02 1.16 ± 0.03 1.32 ± 0.03 0.002/0.002
Gümüs et al. Journal of Orthopaedic Surgery and Research  (2015) 10:161 Page 5 of 6
literature such as NGF, as well as substantiating other
growth factors such as IGF-1, which has positive effects
in nerve tissue healing [8, 10].
The current study is not without limitations. The dur-
ation of the study could have been prolonged to draw
better conclusions with regard to functional evaluation.
Also, we did not examine the effect of the oxytocin on
the different cytotoxins that promotes nerve regeneration.
Future studies should focus on the exact mechanism that
provides nerve healing after oxytocin administration. In
spite of these limitations, these data provide evidence
that oxytocin administration plays a direct role in
nerve regeneration
The strengths of this study are the appropriately pow-
ered histological measure (stereomicroscope) and ana-
lysis of nerve healing in two different injury models. In
addition, assessment of nerve regeneration conducted in
three different ways consisting of functional, electrophysi-
ologic, and structural evaluations. Understanding these
mechanisms may ultimately lead to improvements in per-
ipherical nerve damage.
Our findings show that oxytocin promotes functional
recovery and enhances nerve regeneration after transac-
tional and defective peripheral nerve injury in rats com-
pared with controls. The dose response to oxytocin has
not been described in the present study Future studies
should be performed with different doses to determine
clinical application.
In conclusion, these data clearly demonstrated that
oxytocin promotes nerve healing in two different rat sci-
atic damage models. This healing effect can at least in
part be ascribed to the fact that oxytocin activates growth
factors of importance for the healing of different tissues.
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